Concurrent Chemoradiotherapy Increases the Levels of Soluble Immune Checkpoint Proteins in Patients with Locally Advanced Cervical Cancer

PURPOSE: Concurrent chemoradiotherapy (CCRT) has been widely applied to locally advanced cervical cancer (LACC) patients, inducing the massive release of antigen and systematic immunomodulatory effects. However, its effect on the soluble immune checkpoint proteins (sICPs) remains unclear, which migh...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chao, Li, Xiaohui, Li, Aijie, Zou, Wenxue, Huang, Rui, Hu, Xiaoyu, Yu, Jinming, Zhang, Xiaoling, Yue, Jinbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001122/
https://www.ncbi.nlm.nih.gov/pubmed/35419462
http://dx.doi.org/10.1155/2022/9621466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001122/
https://www.ncbi.nlm.nih.gov/pubmed/35419462
http://dx.doi.org/10.1155/2022/9621466

Ejemplares similares